Clinical Trial: Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07792408) titled 'Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives' on Aug. 25.

Brief Summary: The purpose of the study is to evaluate the pharmacokinetic effects and safety and tolerability of VX-407 when coadministered with oral contraceptives.

Study Start Date: Aug. 28

Study Type: INTERVENTIONAL

Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Intervention: DRUG: VX-407

Tablets for Oral Administration.

DRUG: LNG/EE

Combination Tablets for Oral Administration.

DRUG: NGM/EE

Combination Tablets for Oral Administration.

DRUG: NET/EE

Combination Tablets for Oral Administration.

DRUG: DRSP/EE

Combin...